4.7 Article

Glycosaminoglycans from Litopenaeus vannamei Inhibit the Alzheimer's Disease β Secretase, BACE1

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Protective effects of chondroitin sulphate nano-selenium on a mouse model of Alzheimer's disease

Dongsheng Ji et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)

Review Pharmacology & Pharmacy

Alzheimer's disease: Recent treatment strategies

Miguel Vaz et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Review Pharmacology & Pharmacy

Developments with multi-target drugs for Alzheimer's disease: an overview of the current discovery approaches

Juan F. Gonzalez et al.

EXPERT OPINION ON DRUG DISCOVERY (2019)

Article Clinical Neurology

Alzheimer's disease drug development pipeline: 2019

Jeffrey Cummings et al.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)

Review Biochemistry & Molecular Biology

Marine glycosaminoglycan-like carbohydrates as potential drug candidates for infectious disease

Courtney J. Mycroft-West et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2018)

Article Biochemistry & Molecular Biology

Effect of cellular polyanion mimetics on tau peptide aggregation

Tania Ismail et al.

JOURNAL OF PEPTIDE SCIENCE (2018)

Review Biotechnology & Applied Microbiology

Glycosaminoglycans from marine sources as therapeutic agents

Jesus Valcarcel et al.

BIOTECHNOLOGY ADVANCES (2017)

Review Microbiology

The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics

Ariana A. Vasconcelos et al.

MICROORGANISMS (2017)

Editorial Material Hospitality, Leisure, Sport & Tourism

BACE1 inhibition as a therapeutic strategy for Alzheimer's disease

Robert Vassar

Journal of Sport and Health Science (2016)

Article Multidisciplinary Sciences

Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy

Andras Micsonai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Chemistry, Analytical

NMR Chemical Shifts in Structural Biology of Glycosaminoglycans

Vitor H. Pomin

ANALYTICAL CHEMISTRY (2014)

Article Chemistry, Applied

A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential

Adriana S. Brito et al.

CARBOHYDRATE POLYMERS (2014)

Review Immunology

Glycosaminoglycans analogs from marine invertebrates: structure, biological effects, and potential as new therapeutics

Mauro S. G. Pavao

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)

Article Biochemical Research Methods

Surface plasmon resonance, fluorescence, and circular dichroism studies for the characterization of the binding of BACE-1 inhibitors

Angela De Simone et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)

Review Biochemistry & Molecular Biology

Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing

Stefan F. Lichtenthaler et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Glycosaminoglycan-induced activation of the β-secretase (BACE1) of Alzheimer's disease

David W. Klaver et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Review Medicine, General & Internal

MECHANISMS OF DISEASE Alzheimer's Disease

Henry W. Querfurth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Rheumatology

Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations

Yves Henrotin et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2010)

Review Environmental Sciences

Alzheimer's Disease: Another Target for Heparin Therapy

Luigi Bergamaschini et al.

THESCIENTIFICWORLDJOURNAL (2009)

Article Biochemistry & Molecular Biology

Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp

Adriana S. Brito et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production

Hideaki Shimizu et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Article Clinical Neurology

Engineered heparins: Novel beta-secretase inhibitors as potential Alzheimer's disease therapeutics

S. J. Patey et al.

NEURODEGENERATIVE DISEASES (2008)

Article Biochemistry & Molecular Biology

Chondroitinase-mediated degradation of rare 3-O-sulfated glucuronic acid in functional oversulfated chondroitin sulfate K and E

Duriya Fongmoon et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Pharmacology & Pharmacy

Heparin oligosaccha rides as potential therapeutic agents in senile dementia

Qing Ma et al.

CURRENT PHARMACEUTICAL DESIGN (2007)

Article Biochemical Research Methods

The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability

Frank H. Niesen et al.

NATURE PROTOCOLS (2007)

Article Biochemical Research Methods

High sensitivity separation and detection of heparan sulfate disaccharides

M. A. Skidmore et al.

JOURNAL OF CHROMATOGRAPHY A (2006)

Article Biochemistry & Molecular Biology

Heparin activates β-secretase (BACE1) of Alzheimer's disease and increases autocatalysis of the enzyme

Marie Beckman et al.

BIOCHEMISTRY (2006)

Article Biochemical Research Methods

Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery

MC Lo et al.

ANALYTICAL BIOCHEMISTRY (2004)

Article Neurosciences

BACE1 is the major β-secretase for generation of Aβ peptides by neurons

HB Cai et al.

NATURE NEUROSCIENCE (2001)

Article Biochemistry & Molecular Biology

A novel heparan sulphate with high degree of N-sulphation and high heparin cofactor-II activity from the brine shrimp Artemia franciscana

SF Chavante et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2000)